Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events.
Boursier J, Hagström H, Ekstedt M, Moreau C, Bonacci M, Cure S, Ampuero J, Nasr P, Tallab L, Canivet CM, Kechagias S, Sánchez Y, Dincuff E, Lucena A, Roux M, Riou J, Trylesinski A, Romero-Gomez M.
Boursier J, et al. Among authors: moreau c.
J Hepatol. 2022 May;76(5):1013-1020. doi: 10.1016/j.jhep.2021.12.031. Epub 2022 Jan 19.
J Hepatol. 2022.
PMID: 35063601